HIV & Pregnancy: Other Issues
Nutrition and HIV for Moms-to-Be (December 5, 2012)
From TheBody.com
- Keeping My Promise; Loving My Self (March 6, 2012)
From Black AIDS Institute
- Reyataz (Atazanavir) Label Revised, Adding Dosing Recommendations for Pregnancy and Postpartum Period (February 4, 2011)
From U.S. Food and Drug Administration
- Women With HIV Deserve Abortion Coverage: Tell the White House! (October 5, 2010)
From Positive Women's Network of the United States of America
- Taking HIV Meds Throughout Pregnancy Does More Good Than Harm, Study Suggests (September 15, 2008)
From aidsmap.com
- HIV Meds During Pregnancy Do Not Increase Birth Defect Risk, Major Study Finds (March 27, 2007)
- Six-Month Delay in Onset of Nevirapine-Based Antiretroviral Therapy Can Prevent Drug Resistance Following Single-Dose Nevirapine During Labor, Study Says (January 11, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Exposure to ARVs in Womb Does Not Affect Child's Mental Development, Canadians Report (October 31, 2006)
From aidsmap.com
- Nevirapine Resistance May Persist in Some Pregnant Women, Study Finds (May 3, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
On TheBodyPRO.com
- Efavirenz-Associated Neural Tube Defects Reported in Infants; Pregnancy Category Changed From C to D (March 31, 2005)
From U.S. Food and Drug Administration
- Crixivan (Indinavir) Label Revised -- Not Recommended for HIV-Infected Pregnant Patients (December 27, 2004)
From U.S. Food and Drug Administration
- Nelfinavir Levels a Third Lower in Pregnant Women (August 31, 2004)
However, the reduction doesn't appear to increase the baby's risk of contracting HIV, and in all but one case the pregnant women still had undetectable viral loads.
From aidsmap.com
- HIV Drug Classifications for Pregnant Women (May 25, 2004)
A brief review of which HIV medications have been studied for their safety in pregnant women.
To read PDF, click here.
From PositiveWords
- California: Program Helps Pregnant Mothers Infected With HIV (May 13, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Birth Defect in Baby Born to Efavirenz User (February 6, 2002)
From Canadian AIDS Treatment Information Exchange
On TheBodyPRO.com
- Cesarean Section Morbidity (Summer/Autumn 2001)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- FDA Issues Warning About d4T and ddI During Pregnancy (January 22, 2001)
From Canadian AIDS Treatment Information Exchange
- FDA/Bristol Myers Squibb Issues Caution for HIV Combination Therapy With Zerit and Videx in Pregnant Women (January 5, 2001)
From U.S. Food and Drug Administration
- Important Drug Warning (January 5, 2001)
From U.S. Food and Drug Administration
- Preventing Mother-to-Child HIV Transmission (October 25, 2000)
Technical experts recommend use of antiretroviral regimens beyond pilot projects.
From UNAIDS
- Benefits of Resistance Testing During Pregnancy (December 1999)
In WISE Words, from Project Inform
|
Advertisement
|